Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -202620252024202320222021202020192018201720162015 4 April 2023 Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platform Non-regulated information 31 March 2023 Disclosure of Outstanding Voting Securities Regulated information 29 March 2023 Biocartis To Publish 2022 Annual Report on 11 April 2023 Regulated information 3 March 2023 Disclosure of transparency notification Regulated information 2 March 2023 Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test Non-regulated information 28 February 2023 Disclosure of Outstanding Voting Securities Regulated information 24 February 2023 Biocartis Creates New Share Option Plan and Cancels Outstanding Pool under Existing Share Option Plans Regulated information 23 February 2023 Biocartis announces 2022 results and 2023 outlook Regulated information 22 February 2023 Biocartis announces change in Board composition Non-regulated information 16 February 2023 Biocartis announces 2022 full year results on 23 February 2023 Regulated information Pagination First page « First Previous page ‹‹ Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page ›› Last page Last »